Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
84%
upside
5 price targets
|
0
%
|
|
|
|
83%
upside
17 price targets
|
0
%
|
|
|
|
83%
upside
4 price targets
|
0
%
|
|
|
179
Vera Therapeutics
VERA
$3.05B
|
83%
upside
7 price targets
|
0
%
|
|
|
82%
upside
8 price targets
|
0
%
|
|
|
|
82%
upside
3 price targets
|
0
%
|
|
|
|
82%
upside
13 price targets
|
0
%
|
|
|
|
82%
upside
4 price targets
|
0
%
|
|
|
|
81%
upside
6 price targets
|
0
%
|
|
|
|
81%
upside
10 price targets
|
0
%
|
|
|
186
ArriVent BioPharma
AVBP
$904M
|
81%
upside
3 price targets
|
0
%
|
|
|
81%
upside
4 price targets
|
0
%
|
|
|
|
81%
upside
7 price targets
|
0
%
|
|
|
|
81%
upside
6 price targets
|
0
%
|
|
|
|
80%
upside
4 price targets
|
0
%
|
|
|
|
80%
upside
6 price targets
|
0
%
|
|
|
|
80%
upside
3 price targets
|
0
%
|
|
|
|
80%
upside
4 price targets
|
0
%
|
|
|
|
80%
upside
3 price targets
|
0
%
|
|
|
|
80%
upside
3 price targets
|
0
%
|
|
|
|
79%
upside
7 price targets
|
0
%
|
|
|
|
78%
upside
6 price targets
|
0
%
|
|
|
|
78%
upside
5 price targets
|
0
%
|
|
|
|
78%
upside
6 price targets
|
0
%
|
|
|
|
77%
upside
6 price targets
|
0
%
|
|